DICOM PS3.3 2024e - Information Object Definitions |
---|
Table C.34.15-1 specifies the Attributes of the Protocol Approval Module, which record approvals by a person or device of the content of one or more SOP Instances containing protocols.
An approval is modeled as a form of Assertion. The nature of the approval is defined by the Assertion Code in the embedded Assertion Macro.
Neither the Protocol Approval Module nor the underlying Assertion Macro address securing the approved Instance against tampering (e.g., via a digital hash) or authenticating the identity of the source of the Assertion.
Table C.34.15-1. Protocol Approval Module Attributes
Instances that are the subject of the Approval Sequence. All Assertions in the Approval Sequence (0044,0100) apply to all Instances in this Sequence. |
|||
>Include Table 10-11 “SOP Instance Reference Macro Attributes” |
|||
Assertion Code Sequence (0044,0101) BCID 800 “Protocol Assertion”. The Approver is recorded in the Asserter Identification Sequence inside the Assertion Macro. |
|||
Institution or organization for which use of the protocol is approved/disapproved or eligible/ineligible for reimbursement. NoteThe institution identified by the code can represent a hospital network, a hospital, a clinic or a department. An institution can assign codes for it's subsidiary organizations. Required if Assertion Code Sequence (0044,0101) is (128603, DCM, "Approved for use at the institution") or (128623, DCM, "Disapproved for use at the institution") or (128613, DCM, "Eligible for reimbursement") or (128614, DCM, "Eligible for reimbursement on per patient basis") or (128615, DCM, "Ineligible for reimbursement"). |
|||
Identifier of the clinical trial protocol for which use of the protocol is approved or disapproved. Required if Assertion Code Sequence (0044,0101) is (128604, DCM, "Approved for use in the clinical trial") or (128624, DCM, "Disapproved for use in the clinical trial") or (128611, DCM, "Approved for experimental use") or (128612, DCM, "Disapproved for experimental use"). |
The institution for which use of the protocol is approved (recorded in the Approval Sequence (0044,0100) Item) may or may not differ from the institution that is currently responsible for managing the protocol Instance (recorded in the Custodial Organization Sequence (0040,A07C) of the Defined Protocol Instance). Similarly, the clinical trial for which use of the protocol is approved (recorded in the Approval Sequence (0044,0100) Item) may or may not differ from the clinical trial, if any, for which the protocol Instance was originally designed (recorded in the Clinical Trial Context of the Defined Protocol Instance).
A number of the Assertion codes in CID 800 “Protocol Assertion” affirm details related to Attributes in a Protocol object. The Protocol Attributes associated with each Assertion code are shown in Table C.34.15-2. A receiving system might display the associated Attribute contents together with the Assertion code to convey the full meaning of the Assertion.
Table C.34.15-2. Associated Attributes for Protocol Assertion Codes
DICOM PS3.3 2024e - Information Object Definitions |
---|